• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

Reccomended: Fountain of Youth found in Bile?


  • Please log in to reply
16 replies to this topic

#1 babcock

  • Guest
  • 299 posts
  • 73
  • Location:USA

Posted 16 September 2010 - 02:09 PM


From Science Daily today: http://www.scienceda...00915100935.htm

The human quest for longer life may be one step closer, thanks to research from Concordia University. Published in the journal Aging, a new study is the first to identify the role of a bile acid, called lithocholic acid (LCA), in extending the lifespan of normally aging yeast. The findings may have significant implications for human longevity and health, as yeast share some common elements with people.

"Although we found that LCA greatly extends yeast longevity, yeast do not synthesize this or any other bile acid found in mammals," says senior author Vladimir Titorenko, Concordia University Research Chair in Genomics, Cell Biology and Aging and a professor in the Department of Biology. "It may be that yeast have evolved to sense bile acids as mildly toxic molecules and respond by undergoing life-extending changes. It is conceivable that the life-extending potential of LCA may be relevant to humans as well."


Quick read. Disappointing that the test subjects are yeast, due to their distance from resembling humans at all. Thoughts?

#2 VidX

  • Guest
  • 865 posts
  • 137

Posted 16 September 2010 - 02:19 PM

My thoughts/guess is that something fundamental (IF it would be) will work regardless what specie we take as a test subject,. like it's with CR..

Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#3 niner

  • Guest
  • 16,276 posts
  • 1,999
  • Location:Philadelphia

Posted 17 September 2010 - 05:55 AM

as yeast share some common elements with people

Carbon, Hydrogen, Nitrogen, Oxygen, Phosphorus, and Sulfur...
  • like x 1

sponsored ad

  • Advert

#4 mwestbro

  • Guest
  • 81 posts
  • 22

Posted 17 September 2010 - 02:58 PM

I'm speaking from ignorance here, so someone will have to tell me if I'm completely off base. Is there any relationship between these results and the recent results with TUDCA, a bile acid prominent in bear bile, that is finding applications as a chaperone molecule to reduce endoplasmic reticulum stress? I believe that TUDCA is being tested in diabetes and various neurological disorders, like Huntington's and Alzheimer's Disease. I have added a relevant abstract below.

Am J Physiol Gastrointest Liver Physiol. 2010 Jul 29. [Epub ahead of print]

Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, trypsin
activation and acinar cell apoptosis while increasing secretion in rat pancreatic
acini.

Malo A, Krüger B, Seyhun E, Schäfer C, Hoffmann RT, Göke B, Kubisch CH.


Background: Endoplasmic reticulum (ER) stress leads to accumulation of un- or
misfolded proteins inside the ER and initiates the unfolded protein response
(UPR). Several UPR components are physiologically involved in pancreatic
development and are pathophysiologically activated during acute pancreatitis.
However, the exact role of ER stress in exocrine pancreatic acini is mainly
unclear. The present study examined the effects of tauroursodeoxycholic acid
(TUDCA), a known ER-chaperone, on acinar function and UPR components. Methods:
Isolated rat pancreatic acini were stimulated by increasing concentrations of
cholecystokinin (CCK-8) with or without preincubation of TUDCA. UPR components
were analyzed, including chaperone binding protein (BiP), protein kinase-like ER
kinase (PERK), X-box binding protein (XBP)-1, c-Jun NH2-terminal kinase (JNK),
CCAAT/ enhancer binding protein homologues protein (CHOP), caspase 3 activation
and apoptosis. In addition, TUDCA effects were measured on amylase secretion,
calcium signaling, trypsin, and cathepsin B activation. Results: TUDCA
preincubation led to an significant increased amylase secretion after CCK-8
stimulation, a 50% reduction of intracellular trypsin activation and reduced
cathepsin B activity, although the effects for cathepsin B were not statistical
significant. Further, TUDCA prevented the CCK-8 induced BiP upregulation,
diminished PERK and JNK phosphorylation, and prohibited the expression of CHOP,
caspase 3 activation and apoptosis. XBP-1 splicing was not altered. Conclusion:
ER stress response mechanisms are activated in pancreatic inflammation. Chemical
chaperones enhance enzyme secretion of pancreatic acini, reduce ER stress
responses and attenuate ER stress associated apoptosis. This data hints new
perspectives for an employment of chemical chaperones in the therapy of acute
pancreatitis.


PMID: 20671193 [PubMed - as supplied by publisher]
  • like x 1

#5 Marios Kyriazis

  • Guest
  • 466 posts
  • 255
  • Location:London UK

Posted 25 September 2010 - 03:14 PM

From Science Daily today: http://www.scienceda...00915100935.htm

The human quest for longer life may be one step closer, thanks to research from Concordia University. Published in the journal Aging, a new study is the first to identify the role of a bile acid, called lithocholic acid (LCA), in extending the lifespan of normally aging yeast. The findings may have significant implications for human longevity and health, as yeast share some common elements with people.

"Although we found that LCA greatly extends yeast longevity, yeast do not synthesize this or any other bile acid found in mammals," says senior author Vladimir Titorenko, Concordia University Research Chair in Genomics, Cell Biology and Aging and a professor in the Department of Biology. "It may be that yeast have evolved to sense bile acids as mildly toxic molecules and respond by undergoing life-extending changes. It is conceivable that the life-extending potential of LCA may be relevant to humans as well."


Quick read. Disappointing that the test subjects are yeast, due to their distance from resembling humans at all. Thoughts?

I can't see a clear mechanism how this may work on humans. Even if there is a mechanism, there will be problems with administration of the compound which will be inactivated if given by mouth.

#6 Alpharius

  • Guest
  • 52 posts
  • 20
  • Location:Berlin
  • NO

Posted 26 September 2010 - 07:47 PM

Tauroursodeoxycholic acid (TUDCA) can be given orally, and it also shows an effect in regard to other conditions like liver cirrhosis. It undergoes hepatic metabolism, but is still effective on oral route. (1)

The usually used drug is simply called Ursodeoxycholic acid (UDCA). TUDCA is some kind of small molecule chaperone, so it inhibits protein deformation. In an other publication it showed interesting effects on leptin sensitivity and body fat, also the other compound 4-phenylbutyrate had a similar effect. (2) Interesting is also the effect of TUDCA on improving insulin sensitivity, it seems selective for liver and muscle but not for fat tissue, this may be good, shutting off insulin receptors only in adipocytes prolongs longevity and has a nice effect on body composition. (3) UDCA and 4-pb already are used as medications and are as far as I know safe (UDCA is usually given over 1/2 or 1 year).

May be a very interesting compound.

(1)
Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.
Setchell KD, Rodrigues CM, Podda M, Crosignani A.
Gut. 1996 Mar;38(3):439-46.

(2)
Endoplasmic reticulum stress plays a central role in development of leptin resistance.
Ozcan L, Ergin AS, Lu A, Chung J, Sarkar S, Nie D, Myers MG Jr, Ozcan U.
Cell Metab. 2009 Jan 7;9(1):35-51.

(3)
Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women.
Kars M, Yang L, Gregor MF, Mohammed BS, Pietka TA, Finck BN, Patterson BW, Horton JD, Mittendorfer B, Hotamisligil GS, Klein S.
Diabetes. 2010 Aug;59(8):1899-905. Epub 2010
  • like x 1

Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#7 AgeVivo

  • Guest, Engineer
  • 2,114 posts
  • 1,555

Posted 26 September 2010 - 08:17 PM

Anyone here in contact with some researchers to test it in C elegans?

Perhaps (perhaps) Dr Jan Gruber (research sponsored by imminst) would know someone interested (or might be interested)

Edited by AgeVivo, 26 September 2010 - 08:20 PM.


#8 xEva

  • Guest
  • 1,594 posts
  • 24
  • Location:USA
  • NO

Posted 24 September 2014 - 04:55 AM

I believe tauroursodeoxycholic acid (TUDCA) has been overlooked on this forum. It's a very interesting substance, originally found in large quantities in bear bile, and synthesized in Japan in the 1950s. I bumped into it following the links on transthyretin amyloidosis, intrigued by the established facts that senile systemic amyloidosis affects 25% of people over 80 and that most supercentenarians die of systemic amyloidosis too.  Well, apparently 

"Combined Doxycycline and TUDCA treatment (in human tolerable doses) significantly lowered fibrillar Transthyretin (TTR) amyloid deposition in transgenic TTR mouse models. The authors propose this treatment in FAP, particularly in the early stages of disease."

which refers to this study: Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models, 2010, and FAP == familial amyloid polyneuropathy.
 
A paper on TUDCA was mentioned in a mitochondria thread here, but did not get much attention. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease, 2002.
 
It appears that, among other things, TUDCA also acts as a chaperone for proteins and prevents their misfolding, which seems to be the primary cause of various types of amyloidoses. Here is what the current wiki article says:

"Ongoing research is finding TUDCA has diminishing apoptotic effects, helping with cardiac function, Huntington's disease, Parkinson's Disease, and stroke. Recently, TUDCA has been found to have protective effects in the eye, especially concerning retinal degenerative disorders."



Has anyone tried it yet? One can buy powder 5g for ~$20 or 50g for ~$115. It is also a part of various 'liver support' formulas.

Edited by xEva, 24 September 2014 - 05:03 AM.

  • like x 2

#9 tunt01

  • Guest
  • 2,308 posts
  • 414
  • Location:NW

Posted 24 September 2014 - 05:43 AM

 

Has anyone tried it yet? One can buy powder 5g for ~$20 or 50g for ~$115. It is also a part of various 'liver support' formulas.

 

 

 

I took a Jarrow bile factors supplement for about ~2 weeks.  I was having odd persistent chest pains in my upper right chest while being on a very low/extreme version of CR.  I am pretty sure it was gallbladder problems.  I took them to aid digestion and after some diet modification and 2 weeks of the bile factors supplement, I didn't notice any pain further and quit taking them.  IDK if it was the pills or the diet change that mattered.  I didn't notice anything negative, per se.



#10 Logic

  • Guest
  • 2,659 posts
  • 587
  • Location:Kimberley, South Africa
  • NO

Posted 24 September 2014 - 08:30 AM

On a hunch (dare I call it an 'educated' guess!? :) ) I typed
lithocholic acid gut bacteria
into Google.

"...those whose LDL levels went down the most after taking Zocor (simvastatin), a statin medication, had higher levels of bacterial-derived bile acids from three specific gut bacteria - lithocholic acid (LCA), taurolithocholic acid (TLCA), and glycolithocholic acid (GLCA) - compared to those whose LDL levels did not drop as much..."
http://www.medicalne...cles/236068.php

"...lithocholic acid (LCA; 3α-hydroxy-5β-cholan-24-oic acid) are produced solely by microbial biotransforming reactions in the human large intestine...LCA is sulfated in the human liver at the 3-hydroxy position, conjugated at C-24, and excreted back into bile ( 6). The resultant bile acid sulfate is poorly reabsorbed from the gut. Even though 3-sulfo-LCA glycine and taurine conjugates are deconjugated and to some extent desulfated by intestinal bacteria..."
http://www.jlr.org/c...t/47/2/241.full

"...Ciprofloxacin (CPX), a new quinolone antibiotic, is reported to reduce CYP3A expression in the liver...Lithocholic acid (LCA)-producing bacteria in the feces as well as hepatic level of taurine conjugate of LCA were significantly reduced in CPX-treated SPF mice... resulting in lower CYP3A expression..."
http://www.pubfacts....intestinal-flor

Searching for
probiotic lithocholic acid
yields more interesting results.
 
BHT increases CYP3A4 and may be relevant to the effects under investigation.
http://www.longecity...ndpost&p=689170

#11 Logic

  • Guest
  • 2,659 posts
  • 587
  • Location:Kimberley, South Africa
  • NO

Posted 10 October 2014 - 10:56 PM

On a hunch (dare I call it an 'educated' guess!? :) ) I typed
lithocholic acid gut bacteria
into Google.

"...those whose LDL levels went down the most after taking Zocor (simvastatin), a statin medication, had higher levels of bacterial-derived bile acids from three specific gut bacteria - lithocholic acid (LCA), taurolithocholic acid (TLCA), and glycolithocholic acid (GLCA) - compared to those whose LDL levels did not drop as much..."
http://www.medicalne...cles/236068.php

"...lithocholic acid (LCA; 3α-hydroxy-5β-cholan-24-oic acid) are produced solely by microbial biotransforming reactions in the human large intestine...LCA is sulfated in the human liver at the 3-hydroxy position, conjugated at C-24, and excreted back into bile ( 6). The resultant bile acid sulfate is poorly reabsorbed from the gut. Even though 3-sulfo-LCA glycine and taurine conjugates are deconjugated and to some extent desulfated by intestinal bacteria..."
http://www.jlr.org/c...t/47/2/241.full

"...Ciprofloxacin (CPX), a new quinolone antibiotic, is reported to reduce CYP3A expression in the liver...Lithocholic acid (LCA)-producing bacteria in the feces as well as hepatic level of taurine conjugate of LCA were significantly reduced in CPX-treated SPF mice... resulting in lower CYP3A expression..."
http://www.pubfacts....intestinal-flor

Searching for
probiotic lithocholic acid
yields more interesting results.
 
BHT increases CYP3A4 and may be relevant to the effects under investigation.
http://www.longecity...ndpost&p=689170


Nothing? WTF!?!?  :sad:


  • dislike x 1

#12 xEva

  • Guest
  • 1,594 posts
  • 24
  • Location:USA
  • NO

Posted 11 October 2014 - 12:44 AM

 

Nothing? WTF!?!?  :sad:

 

 

 

And what did you expect from your seemingly random collection of quotes pertaining to lithocholic acid and gut bacteria? To my knowledge, bile acids are not absorbed from the large intestine, and that's where the bulk of gut bacteria reside (in fact, not much is absorbed from the large intestine other than water and some very small molecules -- while bile salts are absorbed in the last portion of ileum).

 

So, the relevance of gut bacteria contributing -- or not -- to the bile acids pool is questionable. Same for BHT -- what does it have to do with bile, other than you got to it via CYP3A4, to which you got through cipro, to which you got through gut bacteria -? Is it some free association exercise? 

 

On the other hand, oral TUDCA should be well absorbed and apparently is, judging by its long history of use in traditional Chinese medicine (as bear bile).  



#13 Logic

  • Guest
  • 2,659 posts
  • 587
  • Location:Kimberley, South Africa
  • NO

Posted 11 October 2014 - 06:43 PM

And what did you expect from your seemingly random collection of quotes pertaining to lithocholic acid and gut bacteria? To my knowledge, bile acids are not absorbed from the large intestine, and that's where the bulk of gut bacteria reside (in fact, not much is absorbed from the large intestine other than water and some very small molecules -- while bile salts are absorbed in the last portion of ileum).

So, the relevance of gut bacteria contributing -- or not -- to the bile acids pool is questionable. Same for BHT -- what does it have to do with bile, other than you got to it via CYP3A4, to which you got through cipro, to which you got through gut bacteria -? Is it some free association exercise?

On the other hand, oral TUDCA should be well absorbed and apparently is, judging by its long history of use in traditional Chinese medicine (as bear bile).


Thx so much for your reply xEva.
I am trying to learn and this kind of criticism is exactly what's required! :)

In hindsight I suppose 'some free association exercise' is a good way of putting it and I should concentrate on making my line of thinking clearer?
:wacko:

(Just to be clear; my post is about lithocholic acid, (LCA) which this thread started with, not the very interesting tauroursodeoxycholic acid. (TUDCA)

Also  the assumption that lithocholic acid has the same effect in humans as it has in yeast is made.)

 

What I meant to say was:

  • The links show that that lithocholic acid is produced in the gut and that the level can be manipulated, although 'Floxing' quinolone based antibiotics and statins would be the very last thing to try, if at all!  Supplementing with the right breed of pro and pre biotics would be what I would research.
  • Also one of the effects of increasing lithocholic acid is an increase in CYP3A4.  If further research finds that this downstream increase in CYP3A4 is the reason for the advantages seen from lithocholic acid; then research into ways of increasing lithocholic acid may be circumvented by simply supplementing with BHT.  The fact that this was a study on yeast has to be kept in mind here.

I hope that is better put?

 

Also I disagree with  your assertion that lithocholic acid is not absorbed through the gut:
From my second link:
Bile salt biotransformations by human intestinal bacteria
http://www.jlr.org/c...t/47/2/241.full

"...During the enterohepatic circulation, bile salts encounter populations of facultative and anaerobic bacteria of relatively low numbers and diversity in the small bowel. Bile salt metabolism by small bowel microbes consists mainly of deconjugation and hydroxy group oxidation. Ileal bile salt transport is highly efficient (∼95%), but approximately 400–800 mg of bile salts escapes the enterohepatic circulation daily and becomes substrate for significant microbial biotransforming reactions in the large bowel ( 6). Comparison of bile acid composition in the gallbladder and feces illustrates the extent of microbial bile acid metabolism in the large intestine ( Fig. 3 ). The secondary bile acids deoxycholic acid (DCA; 3α,12α-dihydroxy-5β-cholan-24-oic acid) and lithocholic acid (LCA; 3α-hydroxy-5β-cholan-24-oic acid) are produced solely by microbial biotransforming reactions in the human large intestine. DCA accumulates in the bile acid pool (LCA to a much lesser extent) as a result of passive absorption through the colonic mucosa and the inability of the human liver to 7α-hydroxylate DCA and LCA to their respective primary bile acids. LCA is sulfated in the human liver at the 3-hydroxy position, conjugated at C-24, and excreted back into bile ( 6). The resultant bile acid sulfate is poorly reabsorbed from the gut. Even though 3-sulfo-LCA glycine and taurine conjugates are deconjugated and to some extent desulfated by intestinal bacteria, 3-sulfo-LCA/LCA is lost in feces and does not normally accumulate in the enterohepatic circulation..."

 

 

I hope this revision of what I was trying to say is more understandable?
I often make posts that are ignored  because no one understands WTF I'm on about it would seem? 
I will try to fix this in future.

Thx again.


Edited by Logic, 11 October 2014 - 06:48 PM.


#14 xEva

  • Guest
  • 1,594 posts
  • 24
  • Location:USA
  • NO

Posted 11 October 2014 - 09:34 PM

Logic, in a human, presence of a substantial quantity of microbes in the small intestine is a pathology called small bowel bacterial overgrowth -- and btw, one of its side effects is impaired absorption of nutrients. Taken together, these two facts imply that whatever bacteria may contribute must be negligible -- unless the resulting molecule is small enough to be easily absorbed.

 

Also I wanted to stress the following: only because some paper showed that gut bacteria produce something, it DOES NOT automatically MEAN that this something is absorbed and utilized. There got to be other studies that demonstrate that this bacterialy produced something finds its way into the circulation. Again, generally, most nutrients --by far!-- are absorbed in the small intestine, while the large intestine is specifically designed to keep most things out.

 

A good example of this is vitamin B12, which is produced in vast quantities by the gut bacteria in the colon -- yet it is not available to the body. To remedy this situation, some animals, like rabbits, are known to ingest their own poop -- iow they run their bacterial contribution through their small intestine where it can be absorbed. And of course you know that in ruminants bacterial fermentation of grasses takes place in the 4-chambered stomach before it hits the small intestine. 

 

 

 

Now, back to the lithocholic acid. First of all, it is the constituent of bile, produced by the liver. That it may be also produced from other bile salts by gut bacteria is irrelevant, because of the uncertainty with both the quantities produced and their absorption -- and in order for  lithocholic acid to have "the same effect in humans as it has in yeast", it must be made and absorbed into the circulation in sufficient quantities.

 

Re CYP3A4 and lithocholic acid, I believe they are vastly different things, but ask niner.

 

 

 

I added my post about TUDCA here, cause that's where it was already mentioned on this forum. And, unlike lithocholic acid, TUDCA is readily available and has a long history of use.  


Edited by xEva, 11 October 2014 - 09:36 PM.


#15 Logic

  • Guest
  • 2,659 posts
  • 587
  • Location:Kimberley, South Africa
  • NO

Posted 13 October 2014 - 12:21 PM

Thanks to Lostfalco's popular
The Microbiome and Brain Enhancement
thread
http://www.longecity...in-enhancement/
I have found a paper that is much easier to read than the 1st one.
 
Bile acids/salts are cholesterol-derived host metabolites that play a role in several host processes (Fig. 2). Their principal functions are to aid in fat adsorption and prevent small intestinal bacterial overgrowth. Both these functions can be explained by the fact that bile acids are surfactants (not detergents), with a hydrophilic taurine or glycine group covalently bound to a hydrophobic steroid (predominantly a C24 structure (Russell 2003))-derived moiety that is wholly derived from cholesterol. This surfactant nature allows them to associate with fat molecules to form micelles, which are ultimately absorbed by the host, thus facilitating fat metabolism. Additionally, being a surfactant allows them to be antimicrobial also, as they can disrupt the plasma membrane of the bacteria, causing them to lyse and die; thus in a niche where food is plentiful, bile helps to prevent the bacteria in the small intestine from overgrowing and becoming a health issue. A secondary role for bile involves regulating the host's cholesterol levels, on a typical day, ∼0.5 g of this steroid is used to synthesise bile acids in hepatocytes and accounts for 90% of the cholesterol usage (Russell 2003). Once the hormonal signal has been sent to the gall bladder, the bile acids are excreted into the small intestine, where they interact with the dietary lipids and fat-soluble vitamins. These complexes are eventually reabsorbed in the terminal ileum; this process is part of the enterohepatic circulation that ensures that 95% of the bile acids are recovered from the gut. The remaining 5% that escapes this pathway enters the large intestine, where it becomes available for metabolism by bacteria. Interestingly, the gut bacteria have evolved several enzymes capable of modifying the primary bile acids such as the taurine- and glycine-conjugated cholic and chenodeoxycholic acids and removing the taurine and glycine parts of the molecules to produce secondary bile salts, such as cholic, lithocholic and deoxycholic acids. While some of these secondary bile acids are excreted in the faeces, a significant proportion are passively absorbed and returned to the liver. These secondary bile acids then enter the enterohepatic circulation and the general bile metabolite pool. The bacterial enzymes responsible for the deconjugation of either taurine or glycine are collectively known as bile salt hydrolases (BSHs), choloylglycine hydrolases or bile acid hydrolases (EC 3.5.1.24) and catalyse the hydrolytic removal of taurine or glycine from the corresponding primary bile acids. However, as with many gut functions, the diversity and abundance of BSHs are highly variable as are their substrate ranges (Jones et al. 2008). Additionally, studies on germ-free rodents (i.e. sterile or gnotobiotic) have shown that the bile pool is significantly and dramatically altered in other non-liver or non-gut compartments too, e.g. heart tissue (Fig. 3), which begs the question of the significance of having a specific BSH profile in the gut and the host's own physiology. Bile acids interact at an endocrinological level via three major signalling mechanisms, as ligands for the G-protein-coupled receptor TGR5, activators of the MAPK pathways and activators of the nuclear hormone receptors such as farnesoid X receptor α (FXRα; NR1H4). While the primary bile acids are of significant interest as they have been shown to regulate lipid, energy and glucose metabolism, the secondary bile acids can also interact with these receptors. However, the availability of the secondary bile acids is not as tightly controlled since it is driven by the variable and dynamic diversity and expression of BSHs in the gut. Hence, the gut microbiota can be thought of as another environmental factor controlling an up-and-coming endocrine factor that is not stable and influenced by diet and medications..."
http://joe.endocrino.../218/3/R37.long
 
So:
bile does prevent bacterial overgrowth,
most is recovered from the gut,
but about 5% is  not and is turned into Secondary Bile Salts in the large intestine.
A significant portion are passively absorbed and returned to the liver.
ie: They enter the general bile metabolite pool where they will affect the endocrine system to some degree.

So research on the effects of LCA s warranted:

LCA can substitute for vitamin D in the elevation of serum calcium in vitamin D-deficient rats by the mobilization of calcium from bone.
But it is hepatotoxic, a tumour promoter, and CYP3A4 is up regulated to protect against its effects!

Refs:
http://www.pnas.org/.../10006.full.pdf
http://www.ncbi.nlm..../pubmed/1641875
http://www.researchg...polymerase_beta
http://www.pubfacts....ne-specific-VDR
http://en.wikipedia.org/wiki/CYP3A4

Thx xEva!
I will now look at TUDCA
:)
  • like x 3

#16 xEva

  • Guest
  • 1,594 posts
  • 24
  • Location:USA
  • NO

Posted 14 October 2014 - 03:36 AM

So:
bile does prevent bacterial overgrowth,
most is recovered from the gut,
but about 5% is  not and is turned into Secondary Bile Salts in the large intestine.
A significant portion are passively absorbed and returned to the liver.
ie: They enter the general bile metabolite pool where they will affect the endocrine system to some degree.

So research on the effects of LCA s warranted:

LCA can substitute for vitamin D in the elevation of serum calcium in vitamin D-deficient rats by the mobilization of calcium from bone.
But it is hepatotoxic, a tumour promoter, and CYP3A4 is up regulated to protect against its effects!
 

 

Thanks Logic, that was an interesting read. So, a "significant portion" of 5% is "passively absorbed and returned to the liver", eh?  ..depending on "the variable and dynamic diversity and expression of BSHs in the gut". 

 

I find that part about LCA elevating "serum calcium in vitamin D-deficient rats by the mobilization of calcium from bone" a bit worrisome.

 

 but hepatotoxic and tumor promoter -?!  Who would want to strive to increase this stuff based on some in vitro yeast study? Yeast don't have livers and they don't get cancer.

 

..though  I'm gonna play with TUDCA.. 



Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#17 Logic

  • Guest
  • 2,659 posts
  • 587
  • Location:Kimberley, South Africa
  • NO

Posted 14 October 2014 - 10:29 PM

Thanks Logic, that was an interesting read. So, a "significant portion" of 5% is "passively absorbed and returned to the liver", eh?  ..depending on "the variable and dynamic diversity and expression of BSHs in the gut". 
 
I find that part about LCA elevating "serum calcium in vitamin D-deficient rats by the mobilization of calcium from bone" a bit worrisome.
 
 but hepatotoxic and tumor promoter -?!  Who would want to strive to increase this stuff based on some in vitro yeast study? Yeast don't have livers and they don't get cancer.
 
..though  I'm gonna play with TUDCA..


:)

Yep; it definitely looks like a false lead except that it may be a good idea to kill off the relevant bacteria or look at increasing CYP3A4. CYP3A4 has been interesting me for a while now.




1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users